The rationale behind an overhaul of the South African healthcare system HEALTH OUTCOMES IN SA Namibia Brazil Chile Mexico Netherlands Zimbabwe Nigeria South Africa Population 2m 186m 16m 107m 16m 13m 144m 47m Life expectancy at birth male 59 68 74 72 77 43 48 50 Life expectancy at birth female 63 75 81 77 81 42 49 52 Healthy life expectancy at birth male 43 57 65 63 70 34 41 43 Healthy life expectancy at birth female 44 62 70 68 73 33 42 45 Child mortality (per 1000): 61 33 10 27 5 86 191 68 Adult mortality male (per 1000) 367 225 128 162 89 771 447 598 Adult mortality female (per 1000) 311 118 64 94 65 789 399 532 Total expenditure on health per capita (USD) 338 765 697 756 3 383 147 50 869 US$ HEALTH OUTCOMES IN SA Top 4 contributors to death HIV/AIDS Infectious diseases CVD Injuries/trauma South Africa has almost the highest incidence of TB (all forms) per 100 000 population and, of the 15 countries with the highest estimated TB incidence in 2005,SA and its neighbours (Botswana, Namibia, Zimbabwe, Mozambique, Lesotho, Zambia, Malawi and Swaziland) provided 9 countries. TB DEATH RATES BY AGE AND GENDER Mortality for ages 15-64 increased substantially from 1997 to 2004 (males 1.8 times, females 2.4 times) More specifically, in certain age groups - death rates for females 20 -29 more than tripled - death rates for males 30 – 44 more than doubled The bulk of these increases is attributable to communicable diseases South Africa is one of only 21 countries (all either in Africa or the former Soviet Union) where life expectancy at birth has declined by 4 years or more between 1990 and 2001. DEATH RATES - AGE AND GENDER 97-04 Communicable and related diseases PUBLIC/PRIVATE SECTOR Population covered: Public – 40 million (84.5%) Private – 7.5 million (15.5%) Expenditure on health: Public – R60 b – funded through tax allocations Private – R64 b – voluntary contributions (except employer based schemes) CONTRIBUTORS TO BAD OUTCOMES Inefficiencies in health not particular to the public sector. A divided healthcare system contributes significantly to the dismal results. Health expenditure on the 7.4 million private beneficiaries is six times that which is spent in the public sector. Contributing to the inefficiencies is the imbalance in human resources in the private sector versus the public sector. One pharmacist for every 1000 beneficiaries in the private sector, and 17 000 beneficiaries to one pharmacist in the public sector. One GP for every 540 beneficiaries in the private sector, and 4000 to every one GP in the public sector. This, amidst a growing burden of disease especially in the public sector. PUBLIC/PRIVATE SECTOR Discrepancies: Provider population pvt vs public Source: UCT MEDICAL SCHEME SPEND Gross income – R74 billion Hospitals – R24 billion 17.5% - 37% of total Pharma (out of hospitals) 11 billion 18.2% - 17.3% of total Specialists – R14 billion 13.7% - 21.7% of total Dentists – R4.9 billion 14.6% GPs - R5.2 billion 18.5% - 8.1% of total Non healthcare costs R9.7 billion Source: CMS Report 2008 MALALIGNNMENT Funders Regulatory reforms on funder side – social solidarity principals. - Social benefit or commodity? Community rating in a voluntary environment FFS environment PMBs Regulated Referred and hospital based care Paid in full MALALIGNNMENT Funders Competition Commissioner ruling Costs increased. Collective guidelines on new technology. Collective blacklisting of fraudulent providers. Collective trade practices e.g. marketing standards. MALALIGNNMENT Providers Uncertainty around NHRPL. Ethical tariff. (3000 extra tariffs in the SAMA Guide to Billing) Members at liberty to go directly to specialists – bypassing gatekeeper. PMB’s - regulated but in the absence of regulated pricing and delivery vehicle for benefits. FRAUD & ABUSE It is estimated that as much as 10% of claims paid are either fraudulent or abusive in some way (depends on the size of the scheme, the nature of the reimbursement models and benefit design). Quality of care decreases because of perverse incentives, e.g. kickbacks; c-section rate Threat to the long term sustainability of the private health care sector. FRAUD & ABUSE Third party payment system Fee for service Incentives are not aligned Weak / overloaded legal system Grey areas between fraud and abuse Conflict between over-servicing and quality care The moral hazard NATIONAL HEALTH INSURANCE Key objectives: Universal coverage – Everyone will have equal access to a comprehensive package of benefits Based on two principles The right to health - meaning that health services will be free at the point of service, therefore there will be mandatory pre-payment. Cross-subsidisation - Income cross-subsidies (to pay according to ability to pay) - Risk cross-subsidies (benefit according to need) NHI Considerations: Funding Earmarked tax - possibly between 3% - 5% of personal income Increased allocations from general tax revenue Possibly RAF & COID The NHI will operate on a single purchaser model, which means that the NHI agency or NDoH will purchase health services for the entire population. The advantage will be in the economies of scale. Single Administrator system? NHI Considerations: Provision Public sector to be the backbone for providing healthcare, BUT - standards in public sector must be raised - resources - governance - infrastructure Accreditation of providers is a key principle. Private‐sector practitioners will be accredited as NHI providers based on their ability to provide services that meet quality standards and their willingness to accept NHI payment levels. THE BHF PROPOSAL Key points of a multi-payer system There is a role for a multi-payer system under a single-purchasing NHI-funded health system. The multi-payer has a key role to play in terms of risk-pooling and provider payment The French NHI system – rated number 1 in the world by the WHO provides universal coverage to comprehensive services through a multi-payer system. The French multi-payer system has been effective in controlling costs whilst at the same time providing improved levels of access to increasing levels of service. THE BHF PROPOSAL Multi-payer systems harness competition to: control costs improve quality and consumer rights through incentives provide expertise to collect data conduct health technology assessment monitor fraud and abuse act as an intermediary between the government and the member resulting in improved accountability and overall governance. THE BHF PROPOSAL It makes for a seamless health financing experience for members of medical schemes and a smooth transition for them into the NHI system. People will not have to terminate their medical scheme membership and be forced into an unknown and at first unpredictable new health financing environment. The model recognizes and protects the constitutional rights of medical scheme members to the quality, scope and levels of care they currently experience. The proposed model precludes the diminution of access by NHI in respect of current members of medical schemes. Medical schemes will continue to collect contributions in respect of optional additional benefits from members. THE BHF PROPOSAL Boards of trustees will be able to play a strong consumer advocacy role. People who previously could not afford to join schemes will find that they now can do so because their contributions are paid by the State. The growth of schemes will ensure continued funding of schemes and volume-based business for scheme administrators. The optional additional benefits offered by schemes will be voluntary but still be able to cater for those who want something over and above the NHI benefits. The existing skill, knowledge and infrastructure of the private funding system will not be lost or wasted but will be harnessed to ensure that NHI works. WIN/WIN SCENARIO Earmarked tax Current budgetary allocation Tax allocations NHI Fund NHI Agency (purchasing, HTA, fraud prevention, etc. Top up Package Top up Package Top up Package Scheme 1 Scheme 2 Scheme 3 NHI Package NHI Package NHI Package Top up Package State Fund? NHI Benefit Package Scheme 4 NHI Package Thank you
© Copyright 2026 Paperzz